Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data (Q31010637)
Jump to navigation
Jump to search
scientific article published on 20 October 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data |
scientific article published on 20 October 2015 |
Statements
1 reference
Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data (English)
1 reference
Jephat Chifamba
1 reference
Viswanathan Mohan
1 reference
Annika Rosengren
1 reference
Salim Yusuf
1 reference
Gilles Dagenais
1 reference
Alvaro Avezum
1 reference
Patricio Lopez-Jaramillo
1 reference
Annamarie Kruger
1 reference
Nahed Monsef
1 reference
Khawar Kazmi
1 reference
Rasha Khatib
1 reference
Harry Shannon
1 reference
Clara Chow
1 reference
Sumathy Rangarajan
1 reference
Li Wei
1 reference
Prem Mony
1 reference
Rajeev Gupta
1 reference
Rajesh Kumar
1 reference
Krishnapillai Vijayakumar
1 reference
Scott A Lear
1 reference
Rafael Diaz
1 reference
Fernando Lanas
1 reference
Khalid Yusoff
1 reference
Noorhassim Ismail
1 reference
Omar Rahman
1 reference
Thandi Puoane
1 reference
Ahmet Temizhan
1 reference
Amiram Gafni
1 reference
PURE study investigators
1 reference
20 October 2015
1 reference
Identifiers
1 reference